Company: SNY
Filing Date: 2025-06-27
Form Type: 11-K
Source: 0001104659-25-063669
Chunk: 18

Company: Sanofi
Filing Date: 2025-06-27
Form: 11-K
Chunk 18
---
 of approximately $4,146,229, realized gains of $40,279, and dividend income of $1,631,140
earned from the investment in the Company’s common stock. The total shares and market value of the company stock held by the Master
Trust at December 31, 2024 were 881,132 and $42,496,960, respectively. During the year ended December 31, 2023, the
Master Trust made purchases of $-0-, sales of approximately $4,993,336, realized gains of $421,926, and dividend income of $1,712,492
earned from the investment in the Company’s common stock. The total shares and market value of the company stock held by the Master
Trust at December 31, 2023 were 1,020,355 and $50,742,243, respectively.

Certain administrative fees have been
paid through a revenue sharing agreement with T. Rowe Price Retirement Plan Services Inc. rather than direct payments and qualify as party-in-interest
transactions.

In addition, certain Plan participants
borrowed from the Plan. As of December 31, 2024 and 2023, the outstanding loans of the Plan participants were $44,961,037 and $43,087,391,
respectively (refer to Note 1 for applicable interest rates). Loans to participants also qualify as party-in-interest transactions.

All of the above transactions are not
considered prohibited transactions pursuant to the prohibited transaction rules of the Department of Labor and Section 408 of
ERISA.

| 6. | Termination of the Plan |

Although it has not expressed any intent
to do so, the Company has the right under the Plan to discontinue its contributions at any time and to terminate the Plan subject to the
provisions of ERISA. Upon such termination of the Plan, the interest of each participant in the trust fund will be distributed to such
participant or his or her beneficiary at the time prescribed by the Plan terms and the Code. In the event of Plan termination, participants would become 100% vested in their employer contributions.

| 7. | Subsequent Events |

Plan management has evaluated all subsequent
events through June 27, 2025, the date the financial statements were issued.

No significant subsequent events were
noted.

<div align='center'>16

SUPPLEMENTAL SCHEDULE

17</div>

Sanofi U.S. Group Savings Plan

| PLAN EIN:    |